Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BiondVax Pharmaceuticals

BiondVax Pharmaceuticals
2003 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
BVXV STOCK SYMBOL
$6.00 SHARE PRICE (As of Friday Closing)
Description

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • Weizmann Science Park
  • PO Box 4143, 14 Einstein Street
  • Ness Ziona 7403618
  • Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BiondVax Pharmaceuticals’s full profile, request a free trial.

BiondVax Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.51 - $7.26 $39.2M $5.77 -$3.16 5.18K 6.54M

BiondVax Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 6,972 8,953
Revenue 0 0 0 0
EBITDA (19,560) (21,359) (9,489) (2,245)
Net Income (20,035) (24,396) (9,606) (2,392)
Total Assets 27,386 28,102 23,505 7,828
Total Debt 26,658 25,054 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BiondVax Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BiondVax Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

BiondVax Pharmaceuticals Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000 00000000(00000 Corporate Backed or Acquired Cambridge, MA 000 000.00 00000000 000.00
To view this company’s complete list of competitors, request access »

BiondVax Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
Ron Babecoff Chief Executive Officer & Founder
Shimon Hassin Ph.D Chief Operating Officer
Tamar Ben-Yedidia Ph.D Chief Scientific Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

BiondVax Pharmaceuticals Board Members (4)

Name Representing Role Since Contact
Info
Avner Rotman Ph.D BiondVax Pharmaceuticals Chairman & Board Member 000 0000
Mark Germain Self Vice Chairman 000 0000
Morris Laster MD Self Board Member 000 0000
Ruth Yakar Ph.D Self Board Member 000 0000